Oncology Drug Delivery Market Report

Japan Oncology Drug Delivery Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 17, 2019
  • PAGES：180
  • REPORT CODE：GMM288778
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Oncology Drug Delivery market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Oncology Drug Delivery market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Drug Delivery industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • NEONC Technologies Inc (NTI)

    • West Pharmaceuticals

    • Becton, Dickinson and Company (BD)

    • Juno Therapeutics, Inc.

    • NEONC Technologies Inc. (NTI)


    By Type:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Drug Delivery Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Oncology Drug Delivery Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.2 Japan Oncology Drug Delivery Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.3 Japan Oncology Drug Delivery Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Oncology Drug Delivery Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Oncology Drug Delivery Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Oncology Drug Delivery Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Oncology Drug Delivery Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Drug Delivery by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Oncology Drug Delivery Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Drug Delivery by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Drug Delivery in Application 1

      • 4.4.2 Market Size and Growth Rate of Oncology Drug Delivery in Application 2

      • 4.4.3 Market Size and Growth Rate of Oncology Drug Delivery in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Oncology Drug Delivery Production Analysis by Regions

    • 5.2 Japan Oncology Drug Delivery Consumption Analysis by Regions


    6 Hokkaido Oncology Drug Delivery Landscape Analysis

    • 6.1 Hokkaido Oncology Drug Delivery Landscape Analysis by Major Types

    • 6.2 Hokkaido Oncology Drug Delivery Landscape Analysis by Major End-Users


    7 Tohoku Oncology Drug Delivery Landscape Analysis

    • 7.1 Tohoku Oncology Drug Delivery Landscape Analysis by Major Types

    • 7.2 Tohoku Oncology Drug Delivery Landscape Analysis by Major End-Users


    8 Kanto Oncology Drug Delivery Landscape Analysis

    • 8.1 Kanto Oncology Drug Delivery Landscape Analysis by Major Types

    • 8.2 Kanto Oncology Drug Delivery Landscape Analysis by Major End-Users


    9 Chubu Oncology Drug Delivery Landscape Analysis

    • 9.1 Chubu Oncology Drug Delivery Landscape Analysis by Major Types

    • 9.2 Chubu Oncology Drug Delivery Landscape Analysis by Major End-Users


    10 Kinki Oncology Drug Delivery Landscape Analysis

    • 10.1 Kinki Oncology Drug Delivery Landscape Analysis by Major Types

    • 10.2 Kinki Oncology Drug Delivery Landscape Analysis by Major End-Users


    11 Chugoku Oncology Drug Delivery Landscape Analysis

    • 11.1 Chugoku Oncology Drug Delivery Landscape Analysis by Major Types

    • 11.2 Chugoku Oncology Drug Delivery Landscape Analysis by Major End-Users


    12 Shikoku Oncology Drug Delivery Landscape Analysis

    • 12.1 Shikoku Oncology Drug Delivery Landscape Analysis by Major Types

    • 12.2 Shikoku Oncology Drug Delivery Landscape Analysis by Major End-Users


    13 Kyushu Oncology Drug Delivery Landscape Analysis

    • 13.1 Kyushu Oncology Drug Delivery Landscape Analysis by Major Types

    • 13.2 Kyushu Oncology Drug Delivery Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 NEONC Technologies Inc (NTI)

      • 14.1.1 NEONC Technologies Inc (NTI) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 West Pharmaceuticals

      • 14.2.1 West Pharmaceuticals Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Becton, Dickinson and Company (BD)

      • 14.3.1 Becton, Dickinson and Company (BD) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Juno Therapeutics, Inc.

      • 14.4.1 Juno Therapeutics, Inc. Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 NEONC Technologies Inc. (NTI)

      • 14.5.1 NEONC Technologies Inc. (NTI) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 133 Figures and 151 Tables)

     

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Oncology Drug Delivery Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Drug Delivery Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Drug Delivery

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Drug Delivery by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Drug Delivery by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Drug Delivery by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Drug Delivery by Different End-Users from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Oncology Drug Delivery Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Oncology Drug Delivery Production by Regions

    • Table Japan Oncology Drug Delivery Production Share by Regions

    • Figure Japan Oncology Drug Delivery Production Share by Regions in 2014

    • Figure Japan Oncology Drug Delivery Production Share by Regions in 2018

    • Figure Japan Oncology Drug Delivery Production Share by Regions in 2026

    • Table Japan Oncology Drug Delivery Consumption by Regions

    • Table Japan Oncology Drug Delivery Consumption Share by Regions

    • Figure Japan Oncology Drug Delivery Consumption Share by Regions in 2014

    • Figure Japan Oncology Drug Delivery Consumption Share by Regions in 2018

    • Figure Japan Oncology Drug Delivery Consumption Share by Regions in 2026

    • Table Hokkaido Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Hokkaido Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Hokkaido Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Hokkaido Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Tohoku Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Tohoku Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Tohoku Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Tohoku Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Tohoku Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Tohoku Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Tohoku Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Tohoku Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Kanto Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kanto Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kanto Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Kanto Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Kanto Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Kanto Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kanto Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kanto Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kanto Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Chubu Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chubu Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chubu Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Chubu Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Chubu Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Chubu Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chubu Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chubu Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chubu Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Kinki Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kinki Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kinki Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Kinki Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Kinki Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Kinki Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kinki Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kinki Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kinki Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Chugoku Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Chugoku Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Chugoku Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Chugoku Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Chugoku Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Chugoku Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Chugoku Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Chugoku Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Shikoku Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Shikoku Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Shikoku Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Shikoku Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Shikoku Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Shikoku Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Shikoku Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Shikoku Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Kyushu Oncology Drug Delivery Consumption by Types from 2014 to 2026

    • Table Kyushu Oncology Drug Delivery Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Oncology Drug Delivery Consumption Share by Types in 2014

    • Figure Kyushu Oncology Drug Delivery Consumption Share by Types in 2018

    • Figure Kyushu Oncology Drug Delivery Consumption Share by Types in 2026

    • Table Kyushu Oncology Drug Delivery Consumption by End-Users from 2014 to 2026

    • Table Kyushu Oncology Drug Delivery Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Oncology Drug Delivery Consumption Share by End-Users in 2014

    • Figure Kyushu Oncology Drug Delivery Consumption Share by End-Users in 2018

    • Figure Kyushu Oncology Drug Delivery Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of NEONC Technologies Inc (NTI)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NEONC Technologies Inc (NTI)

    • Figure Sales and Growth Rate Analysis of NEONC Technologies Inc (NTI)

    • Figure Revenue and Market Share Analysis of NEONC Technologies Inc (NTI)

    • Table Product and Service Introduction of NEONC Technologies Inc (NTI)

    • Table Company Profile and Development Status of West Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of West Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of West Pharmaceuticals

    • Figure Revenue and Market Share Analysis of West Pharmaceuticals

    • Table Product and Service Introduction of West Pharmaceuticals

    • Table Company Profile and Development Status of Becton, Dickinson and Company (BD)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton, Dickinson and Company (BD)

    • Figure Sales and Growth Rate Analysis of Becton, Dickinson and Company (BD)

    • Figure Revenue and Market Share Analysis of Becton, Dickinson and Company (BD)

    • Table Product and Service Introduction of Becton, Dickinson and Company (BD)

    • Table Company Profile and Development Status of Juno Therapeutics, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics, Inc.

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics, Inc.

    • Figure Revenue and Market Share Analysis of Juno Therapeutics, Inc.

    • Table Product and Service Introduction of Juno Therapeutics, Inc.

    • Table Company Profile and Development Status of NEONC Technologies Inc. (NTI)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NEONC Technologies Inc. (NTI)

    • Figure Sales and Growth Rate Analysis of NEONC Technologies Inc. (NTI)

    • Figure Revenue and Market Share Analysis of NEONC Technologies Inc. (NTI)

    • Table Product and Service Introduction of NEONC Technologies Inc. (NTI)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US